HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
OTC Drugs Commercial Advertising, Marketing & Sales

Lumify Ad Launches As Bausch Spends More Behind OTC Eye Care Brands

  • News

Executive Summary

Following first anniversary of Lumify launch, "we're still in a pretty heavy investment period supporting trial because our data suggest that when people use the product, they persist in using the product. And so for now, we got our foot down on of the promotional side," says CFO Paul Herendeen.

Table

View full table

Advertisement

Related Content

Scrip
Adios To Alcon In April As Novartis Confirms Spin-Off Date
HBW Insight
Bausch Health Boosts Ad Spending For Expanding OTC Eye Care Lineup
HBW Insight
Valeant Launches Lumify OTC Eye Drops With Vision Of Better Days As Bausch
Scrip
Valeant's New Strategic Direction: Clean Break Or Simply A Paint Job?

Topics

Related Companies

Advertisement
Tags:
OTC Drugs Commercial Advertising, Marketing & Sales
UsernamePublicRestriction

Register

RS148905

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By